Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.

Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT.

J Immunol. 2004 Jan 15;172(2):1237-45.

3.

Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.

Kim B, Sarangi PP, Lee Y, Deshpande Kaistha S, Lee S, Rouse BT.

J Leukoc Biol. 2006 Dec;80(6):1405-15. Epub 2006 Sep 22.

PMID:
16997857
4.

CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.

West DM, Del Rosso CR, Yin XT, Stuart PM.

J Immunol. 2014 Feb 15;192(4):1762-7. doi: 10.4049/jimmunol.1302957. Epub 2014 Jan 17.

5.

Absence of CXCL10 aggravates herpes stromal keratitis with reduced primary neutrophil influx in mice.

Shen FH, Wang SW, Yeh TM, Tung YY, Hsu SM, Chen SH.

J Virol. 2013 Aug;87(15):8502-10. doi: 10.1128/JVI.01198-13. Epub 2013 May 29.

6.
7.

Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1.

Morris JE, Zobell S, Yin XT, Zakeri H, Summers BC, Leib DA, Stuart PM.

J Immunol. 2012 Jan 15;188(2):793-9. doi: 10.4049/jimmunol.1102251. Epub 2011 Dec 7.

8.

Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.

Xia L, Zhang S, Cao Z, Hu Y, Yang H, Wang D.

Microbes Infect. 2013 Feb;15(2):126-39. doi: 10.1016/j.micinf.2012.10.017. Epub 2012 Nov 14.

PMID:
23159245
9.
10.

Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions.

Twardy BS, Channappanavar R, Suvas S.

Invest Ophthalmol Vis Sci. 2011 Nov 4;52(12):8604-13. doi: 10.1167/iovs.11-8089.

11.
12.

Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis.

Seo SK, Park HY, Choi JH, Kim WY, Kim YH, Jung HW, Kwon B, Lee HW, Kwon BS.

J Immunol. 2003 Jul 15;171(2):576-83.

13.

IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis.

Lee S, Zheng M, Deshpande S, Eo SK, Hamilton TA, Rouse BT.

J Leukoc Biol. 2002 Mar;71(3):469-76.

PMID:
11867684
14.

On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis.

Thomas J, Gangappa S, Kanangat S, Rouse BT.

J Immunol. 1997 Feb 1;158(3):1383-91.

PMID:
9013983
15.

Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.

Mulik S, Xu J, Reddy PB, Rajasagi NK, Gimenez F, Sharma S, Lu PY, Rouse BT.

Am J Pathol. 2012 Aug;181(2):525-34. doi: 10.1016/j.ajpath.2012.04.014. Epub 2012 May 31.

18.
19.

Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.

Bauer D, Lu M, Wasmuth S, Li H, Yang Y, Roggendorf M, Steuhl KP, Heiligenhaus A.

Graefes Arch Clin Exp Ophthalmol. 2006 Feb;244(2):216-25. Epub 2005 Jul 27.

PMID:
16047184
20.

Supplemental Content

Support Center